Verrica Pharmaceuticals

Verrica Pharmaceuticals is a dermatology-focused therapeutics company based in downtown West Chester. Incorporated in 2013, its flagship product is YCANTH, the first FDA-approved treatment for molluscum contagiosum, a common contagious skin infection in children. The company is advancing YCANTH into additional indications, including common warts and external genital warts. Verrica represents the commercial-stage end of Chester County's biotech spectrum, having moved from development into a marketed product.